{"title":"Polystyrene Nanoplastics induced placental toxicology by activating Keap1-mediated ferroptosis via METTL3-dependent m6A methylation.","authors":"Yujiao Chen, Yifan Liu, Meng Zhang, Shanshan Li, Yousheng Yan, Chenghong Yin","doi":"10.1007/s10565-026-10152-9","DOIUrl":null,"url":null,"abstract":"<p><p>Polystyrene nanoplastics (PS-NPs) exposure can induce placental toxicity, but the molecular mechanism of PS-NP-induced placental toxicity is poorly understood. We selected PS-NPs (80 nm) as a model of plastic particles and treated the human trophoblast cell line JEG3 (6.25, 12.5, 25, 50, and 100 mg/L) and pregnant mice with PS-NPs (15, 30 and 60 mg/kg·bw). These results found that PS-NPs regulated key ferroptosis-associated proteins (GPX4, ACSL4, and FTH1), indicating that PS-NPs induced ferroptosis. Here, we show for the first time that PS-NPs trigger placental ferroptosis by disrupting the p62-Keap1 interaction, thereby blocking Nrf2 degradation. Although m6A modification of the p62-Keap1-Nrf2 axis has been described in other models, its involvement in nanoplastic-induced placental injury remains unexplored. Here, we showed that PS-NPs induce ferroptosis by promoting METTL3 expression in JEG cells and placental tissues. Furthermore, knockdown of METTL3 inhibited PS-NP-induced ferroptosis by regulating Keap1 m6A, which inhibited the p62-Keap1-Nrf2 pathway in vitro. PS-NP-induced ferroptosis was attenuated by METTL3 knockdown via the inhibition of Keap1 m6A, which regulates the p62-Keap1-Nrf2 pathway. Collectively, these findings indicate thatMETTL3-mediated m6A methylation induced by PS-NPs may represent a previously unrecognized molecular basis for placental injury.</p>","PeriodicalId":9672,"journal":{"name":"Cell Biology and Toxicology","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13013170/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Biology and Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10565-026-10152-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Polystyrene nanoplastics (PS-NPs) exposure can induce placental toxicity, but the molecular mechanism of PS-NP-induced placental toxicity is poorly understood. We selected PS-NPs (80 nm) as a model of plastic particles and treated the human trophoblast cell line JEG3 (6.25, 12.5, 25, 50, and 100 mg/L) and pregnant mice with PS-NPs (15, 30 and 60 mg/kg·bw). These results found that PS-NPs regulated key ferroptosis-associated proteins (GPX4, ACSL4, and FTH1), indicating that PS-NPs induced ferroptosis. Here, we show for the first time that PS-NPs trigger placental ferroptosis by disrupting the p62-Keap1 interaction, thereby blocking Nrf2 degradation. Although m6A modification of the p62-Keap1-Nrf2 axis has been described in other models, its involvement in nanoplastic-induced placental injury remains unexplored. Here, we showed that PS-NPs induce ferroptosis by promoting METTL3 expression in JEG cells and placental tissues. Furthermore, knockdown of METTL3 inhibited PS-NP-induced ferroptosis by regulating Keap1 m6A, which inhibited the p62-Keap1-Nrf2 pathway in vitro. PS-NP-induced ferroptosis was attenuated by METTL3 knockdown via the inhibition of Keap1 m6A, which regulates the p62-Keap1-Nrf2 pathway. Collectively, these findings indicate thatMETTL3-mediated m6A methylation induced by PS-NPs may represent a previously unrecognized molecular basis for placental injury.
期刊介绍:
Cell Biology and Toxicology (CBT) is an international journal focused on clinical and translational research with an emphasis on molecular and cell biology, genetic and epigenetic heterogeneity, drug discovery and development, and molecular pharmacology and toxicology. CBT has a disease-specific scope prioritizing publications on gene and protein-based regulation, intracellular signaling pathway dysfunction, cell type-specific function, and systems in biomedicine in drug discovery and development. CBT publishes original articles with outstanding, innovative and significant findings, important reviews on recent research advances and issues of high current interest, opinion articles of leading edge science, and rapid communication or reports, on molecular mechanisms and therapies in diseases.